dMMR Colorectal Carcinoma — Trials

dMMR Colorectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 33%
Top sponsor: Ismail Gögenur
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07689812	A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.(SIGNAL-IO 301)	not yet recruiting	N/A	920	Natera, Inc.INDUSTRY	0	Aug 4, 2026	clinicaltrials

Data updated 23 days agoSource updated Aug 4, 2026source: clinicaltrials